New pill shows promise in taming Hard-to-Treat blood cancers
NCT ID NCT02029443
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new oral drug called acalabrutinib (ACP-196) in people with chronic lymphocytic leukemia (CLL) or related blood cancers that have not responded to at least two prior treatments. The goal is to see if the drug is safe and can shrink or control the cancer. About 306 adults took part, and the drug works by blocking a protein that helps cancer cells grow.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Boston, Massachusetts, 2215, United States
-
Research Site
New Hyde Park, New York, 11042, United States
-
Research Site
New York, New York, 10021, United States
-
Research Site
Columbus, Ohio, 43210, United States
-
Research Site
Fort Worth, Texas, 76104, United States
-
Research Site
Salt Lake City, Utah, 84112, United States
-
Research Site
Seattle, Washington, 98122, United States
-
Research Site
Tacoma, Washington, 98405, United States
-
Research Site
Milan, 20132, Italy
-
Research Site
Leeds, LS9 7TF, United Kingdom
-
Research Site
London, SE5 9RS, United Kingdom
-
Research Site
Oxford, OX3 7LE, United Kingdom